Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention
Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention
About this item
Full title
Author / Creator
Kastrati, Adnan , Neumann, Franz-Josef , Mehilli, Julinda , Byrne, Robert A , Iijima, Raisuke , Büttner, Heinz Joachim , Khattab, Ahmed A , Schulz, Stefanie , Blankenship, James C , Pache, Jürgen , Minners, Jan , Seyfarth, Melchior , Graf, Isolde , Skelding, Kimberly A , Dirschinger, Josef , Richardt, Gert , Berger, Peter B , Schömig, Albert and ISAR-REACT 3 Trial Investigators
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Bivalirudin is a new direct thrombin inhibitor. In patients undergoing PCI for stable coronary disease, bivalirudin and unfractionated heparin resulted in similar overall outcomes, but there was less major bleeding with bivalirudin.
Bivalirudin is a new direct thrombin inhibitor. In patients undergoing PCI for stable coronary disease, bivalirudi...
Alternative Titles
Full title
Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention
Authors, Artists and Contributors
Author / Creator
Neumann, Franz-Josef
Mehilli, Julinda
Byrne, Robert A
Iijima, Raisuke
Büttner, Heinz Joachim
Khattab, Ahmed A
Schulz, Stefanie
Blankenship, James C
Pache, Jürgen
Minners, Jan
Seyfarth, Melchior
Graf, Isolde
Skelding, Kimberly A
Dirschinger, Josef
Richardt, Gert
Berger, Peter B
Schömig, Albert
ISAR-REACT 3 Trial Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_69426581
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69426581
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa0802944
